🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Many of the patients with oral lichen planus (OLP) either fail to achieve c...
Status
Recruiting
Location
AIIMS, Bhubaneswar
Start Date
2025-10-10
Trial ID
NCT07131813
Treatments Being Tested
Individuals with Down syndrome (DS) have an increased risk of numerous co-o...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2023-06-29
Trial ID
NCT05662228
Treatments Being Tested
The main objective of this study is to compare the effects of CP-690,550 wi...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2011-03
Trial ID
NCT01309737
Treatments Being Tested
Phase 1 study to describe pharmacokinetics of CP-690,550 in pediatric patie...
Status
Completed
Location
Explorer Clinic, University of Minnesota Children's Hospital
Start Date
2013-03
Trial ID
NCT01513902
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of tofacitinib (...
Status
Completed
Location
Internal Medicine Center, LLC
Start Date
2012-04
Trial ID
NCT01465763
Treatments Being Tested
This study is designed to compare the effectiveness of the experimental dru...
Status
Completed
Location
Catalina Pointe Clinical Research, Inc.
Start Date
2010-01
Trial ID
NCT01039688
Treatments Being Tested
In this study, a 10 mg dose of CP-690,550 will be given to study subjects o...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-07
Trial ID
NCT01143805
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetic (PK) and safet...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2020-06-17
Trial ID
NCT04338711
Treatments Being Tested
This study investigates safety and efficacy of CP-690,550 in adult patients...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-01
Trial ID
NCT00615199
Treatments Being Tested
The current study is designed to estimate the effect of rifampin (600 mg or...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-09
Trial ID
NCT01204112
Treatments Being Tested